SCHEMBL13284002

SCHEMBL13284002

COc1ccccc1-c1csc(C=O)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 1/20 0.56
▸ ATP4A P20648 3/20 0.53
▸ ATP4B P51164 3/20 0.53
▸ VCP P55072 1/20 0.50
▸ HPGDS O60760 1/20 0.49
▸ KDM1A O60341 1/20 0.48
▸ HTR3A P46098 1/20 0.46
▸ SREBF2 Q12772 1/20 0.45
▸ MAPT P10636 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ KMT2A Q03164 2/20 0.44
▸ PTGS2 P35354 1/20 0.44
▸ C1S P09871 1/20 0.44
▸ GSTO1 P78417 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ NPC1 O15118 1/20 0.43
▸ NFKB1 P19838 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ NFKB2 Q00653 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13510369 0.85 CYP19A1 (0.41) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL12510242 0.78 VCP (0.60) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL8695711 0.78 CYP19A1 (0.61) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL234658 0.78 ALDH1A1 (0.63) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL29796690 0.78 ALDH1A1 (0.63) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL27711558 0.78 CYP19A1 (0.61) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL13510366 0.76 HTR2B (0.55) CYP19A1ATP4AATP4BSREBF2MAPT
Iodide SCHEMBL11486465 0.76 ALDH1A1 (0.61) CYP19A1ATP4AATP4BVCPHPGDS
SCHEMBL3193066 0.76 CYP19A1 (0.53) CYP19A1ATP4AATP4BKDM1AMAPT
SCHEMBL27570571 0.76 AR (0.47) MAPTKDM4EKMT2AMEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3064492-B1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME SUMITOMO CHEMICAL CO (JP) 2018-12-26 — — EP disclosed
US-10091998-B2 Tetrazolinone compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-10-09 — — US disclosed
EP-3064492-A1 TETRAZOLINONE COMPOUND AND APPLICATION FOR SAME Sumitomo Chemical Company, Limited (JP) 2016-09-07 — — EP disclosed
US-20160249617-A1 TETRAZOLINONE COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-09-01 — — US disclosed
CN-105683169-A Tetrazolinone compound and application for same 住友化学株式会社 2016-06-15 — — CN disclosed
EP-1856010-B1 METHODS FOR OLIGOMERIZING OLEFINS EXXONMOBIL CHEM PATENTS INC (US) 2010-07-28 — — EP disclosed
US-7642324-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX SOLUTIONS, INC. (US) 2010-01-05 — — US disclosed
US-7642324-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX SOLUTIONS, INC. (US) 2010-01-05 — — US disclosed
US-7642216-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX SOLUTIONS, INC. (US) 2010-01-05 — — US disclosed
US-7642216-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX SOLUTIONS, INC. (US) 2010-01-05 — — US disclosed
US-20090131619-A1 METHODS OF USING HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS SYMYX TECHNOLOGIES, INC. (US) 2009-05-21 — — US disclosed
US-20090131619-A1 METHODS OF USING HETEROCYCLE-AMINE LIGANDS, COMPOSITIONS, COMPLEXES, AND CATALYSTS SYMYX TECHNOLOGIES, INC. (US) 2009-05-21 — — US disclosed
US-20080269443-A1 Methods of oligomerizing olefins EXXONMOBIL CHEMICAL PATENTS INC. 2008-10-30 — — US disclosed
US-20080269443-A1 Methods of oligomerizing olefins EXXONMOBIL CHEMICAL PATENTS INC. 2008-10-30 — — US disclosed
US-7414006-B2 Methods for oligomerizing olefins EXXONMOBIL CHEMICAL PATENTS INC. (US) 2008-08-19 — — US disclosed
US-7414006-B2 Methods for oligomerizing olefins EXXONMOBIL CHEMICAL PATENTS INC. (US) 2008-08-19 — — US disclosed
US-7387980-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. 2008-06-17 — — US disclosed
US-7387980-B2 Methods of using heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. 2008-06-17 — — US disclosed
US-7256296-B2 Heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. (US) 2007-08-14 — — US disclosed
US-7256296-B2 Heterocycle-amine ligands, compositions, complexes, and catalysts SYMYX TECHNOLOGIES, INC. (US) 2007-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160249617-A1 TETRAZOLINONE COMPOUND AND USE THEREOF TCOF1, TAOK2, CYC1 CYP19A1 210/4885ATP4A 2195/4885ATP4B 2414/4885
US-10091998-B2 Tetrazolinone compound and use thereof RO60, MT-CO1, ROS1 CYP19A1 406/4885ATP4A 2230/4885ATP4B 3122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback